@article{acbd4a44d5524aec8819d85e4d9e2b70,
title = "Definitive fusions are better than growing rod procedures for juvenile patients with cerebral palsy and scoliosis: a prospective comparative cohort study",
abstract = "Purpose: This study compared the outcomes of juvenile patients with cerebral palsy (CP) and scoliosis who underwent spinal fusion (SF) versus growing rod (GR) surgery. Methods: Two prospective multicenter registries were queried for patients 8–10 years old with minimum 2-year follow-up who underwent SF or GR surgery (no MCGR). Demographics, radiographs, complications, and outcome scores were recorded. Results: There were 35 patients in the SF and 15 in the GR group. The mean age at surgery was 10 and 9.3 years in the SF and GR groups, respectively (p = 0.004). In the SF group preoperatively, the major curve measured 86° and 80° in the GR group (p = 0.40). “Definitive” surgery in the GR group consisted of SF in 10, implant retention in three, and implant removal in two. The SF group had 60.8% and the GR group had 45.0% correction following “definitive” surgery (p = 0.03). In the SF group, 8 patients and in the GR group, 9 patients (SF = 22.9%, GR = 60.0%) had a complication (p = 0.01). In the SF group, two patients (5.7%) had reoperations for infection; eight patients (53.3%) in the GR group had reoperations for infection and implant complications (p < 0.001). In the SF group, 23/30 parents (76.6%) noted that the child{\textquoteright}s life “improved a lot.” In the GR group, 3/6 parents (50.0%) noted they were “neutral” about their child{\textquoteright}s ability to do things, 2/6 (33.3%) were “very dissatisfied.” Conclusions: SF treatment for juvenile patients with CP and scoliosis resulted in fewer complications and unplanned reoperations and better radiographic outcomes compared with GR. Quality of life improvements were also better in the SF group. Level of evidence: Level III.",
keywords = "Cerebral palsy, Growing rods, Juvenile, Scoliosis, Spinal fusion",
author = "{Pediatric Spine Study Group} and {Harms Study Group} and Hariharan, {Arun R.} and Shah, {Suken A.} and Sponseller, {Paul D.} and Burt Yaszay and Glotzbecker, {Michael P.} and Thompson, {George H.} and Cahill, {Patrick J.} and Bastrom, {Tracey P.}",
note = "Funding Information: ARH has no relevant financial or non-financial interests to disclose. SAS reports royalties from DePuy Synthes, Globus Medical, Stryker; consulting fees from DePuy Synthes, Misonix; board or committee member of American Academy of Orthopaedic Surgeons, American Orthopaedic Association, Pediatric Orthopaedic Society of North America, and Scoliosis Research Society; other financial or non-financial interests from DePuy Synthes and Pacira-speaker, DePuy and Stryker-principal investigator, outside the submitted work. PDS reports royalties from Globus Medical; consulting fees from OrthoPediatrics, DePuy Synthes; payment from DePuy Synthes; support for attending meetings or travel from DePuy Synthes; leadership or fiduciary role in Scoliosis Research Society, outside the submitted work. BY reports institutional support from the Setting Scoliosis Straight Foundation; royalties from Stryker/K2M, NuVasive, Globus Medical, OrthoPediatrics; consulting fees from Stryker, NuVasive, DePuy Synthes, Biogen, Medtronic; payment from Stryker, DePuy Synthes, NuVasive; payments planned from Stryker/K2M; board member of Medtronic, outside the submitted work. MPG reports consulting fees from NuVasive, Orthobullets; payment from NuVasive, DePuy Synthes, Zimmer Biomet; stock in Orthobullets, outside the submitted work. GHT reports royalties from OrthoPediatrics; consulting fees from OrthoPediatrics; course development, honoraria from Broadwater, salary as Executive Editor of Journal of Pediatric Orthopaedics from Wolters Kluwer; support from NuVasive, Scoliosis Research Society, Shriners Hospital for Children Medical Advisory Board; participation in SHC Medical Advisory Board; leadership role in SHC-Interim Chief Medical Officer, Scoliosis Research Society-historian, SICOT Foundation-Executive Director; stock in OrthoPediatrics, outside of submitted work. PJC reports grants to Setting Scoliosis Straight Foundation in support of Harms Study Group, Children{\textquoteright}s Spine Study Group; consulting fees from Biogen, NuVasive; patent for dynamic lung magnetic resonance imaging but has not been commercialized or received any monetary payment; board or committee member of American Academy of Orthopaedic Surgeons, editorial or governing board of Journal of Bone and Joint Surgery-American, board or committee member of Pediatric Orthopaedic Society of North America and Scoliosis Research Committee, editorial or governing board of Spine Deformity, outside of submitted work. TPB reports support from Setting Scoliosis Straight Foundation, outside of submitted work. PSSG reports grants from Zimmer Biomet, DePuy Synthes, Medtronic, OrthoPediatrics, NuVasive, Globus Medical, Stryker, Pediatric Spine Foundation, outside the submitted work. HSG reports this study was supported in part by grants to the Setting Scoliosis Straight Foundation in support of Harms Study Group research from DePuy Synthes, EOS imaging, Stryker, Medtronic, NuVasive, Zimmer Biomet, and the Food and Drug Administration; patient education grants from Globus Medical, Medicrea, Abbot Laboratories, Green Sun Medical, Ability Orthotics, CD Denison Orthopedic Appliance Group, in support of Setting Scoliosis Straight Foundation education events, outside the submitted work. Publisher Copyright: {\textcopyright} 2022, The Author(s), under exclusive licence to Scoliosis Research Society.",
year = "2023",
month = jan,
doi = "10.1007/s43390-022-00577-7",
language = "English (US)",
volume = "11",
pages = "145--152",
journal = "Spine deformity",
issn = "2212-134X",
publisher = "Elsevier BV",
number = "1",
}